Moreover, overactivation of NF-κB signaling is evident in many chronic inflammatory disorders, such as inflammatory bowel disease (IBD) [28,29], rheumatoid arthritis (RA) [30], and psoriasis, among others [28,30,31,32,33] (Table 1). Here, NFKB1 is linked to inflammatory bowel disease.